Among Polish women who carry a truncating CHEK2 mutation without a family history of breast cancer, the risk increase is about three-fold, and the risk is higher (increased about five-fold) in carriers of a truncating mutation of CHEK2 in the presence of positive family history of breast cancer [4]. This evidence concerns the gene CHEK2 and breast carcinoma.